The Rare Air of Elevation Oncology: Raising Nearly $200M in 2 Years, with CEO Shawn Leland
Elevation Oncology has raised nearly $200M since its launch just two years ago. $200 million! That sounds like an enormous amount of investment capital, but when the company is potentially changing cancer treatment as we know it - you can see why investors are excited about Elevation's potential. Today, founder and CEO Shawn Leland tells us all about the raises, challenges and excitement of growing his company.